This is an annual Congress focusing on neurology, with topics ranging from neurodegenerative diseases to genetic therapy. The event is open to scientists, academics, researchers, healthcare professionals, regulators, and industry experts, and provides a forum for sharing and collaborating to identify future trends within the field.
Date
Oct 27, 2019 - Oct 31, 2019
Location
Dubai, UAE
Bringing over 4,000 science experts from 126 countries, this year's Congress has for theme "Accelerating the pace of change".
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.